Anavex Life Sciences Corp. (AVXL) earnings
AVXL earnings moved a median of -3.44% by the close. Quarterly and annual AVXL reports and results, each read against the price at its own news timestamp. Back to the AVXL overview →
16 measured AVXL earnings events.
Where these AVXL earnings landedvs 16 measured AVXL earnings reactions
| Middle 50% of AVXL earnings reactions | -5.20% to +1.35% |
|---|---|
| Median reaction (to close) | -3.44% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 AVXL earnings events with a measured close landed between -5.20% and +1.35%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A ANAVEX LIFE SCIENCES For: Sep 30 | SEC filing · Form 10-K | +0.17% | -5.08% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Jun 30 | SEC filing · Form 10-Q | +0.17% | -5.08% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Mar 31 | SEC filing · Form 10-Q | +0.17% | -5.08% | |
| Form 10-Q/A ANAVEX LIFE SCIENCES For: Dec 31 | SEC filing · Form 10-Q | +0.17% | -5.08% | |
| Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update | Press release | +2.79% | +7.57% | |
| Form NT 10-Q ANAVEX LIFE SCIENCES For: Mar 31 | SEC filing · Form NT | +0.00% | -5.56% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Dec 31 | SEC filing · Form 10-Q | -1.38% | -8.76% | |
| Form 10-K ANAVEX LIFE SCIENCES For: Sep 30 | SEC filing · Form 10-K | +1.13% | +8.73% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Jun 30 | SEC filing · Form 10-Q | +1.16% | -1.77% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Mar 31 | SEC filing · Form 10-Q | +2.30% | -0.97% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Dec 31 | SEC filing · Form 10-Q | +2.38% | +8.75% | |
| Form 10-K ANAVEX LIFE SCIENCES For: Sep 30 | SEC filing · Form 10-K | -0.32% | -5.64% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Jun 30 | SEC filing · Form 10-Q | +2.01% | -12.52% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Mar 31 | SEC filing · Form 10-Q | -2.32% | -1.80% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Dec 31 | SEC filing · Form 10-Q | +0.71% | +0.53% | |
| Form 10-K ANAVEX LIFE SCIENCES For: Sep 30 | SEC filing · Form 10-K | -1.69% | +3.83% |
Keep exploring
More AVXL: analyst actions → · SEC filings → · AVXL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NEWLINK GENETICS (NLNK) | 843 | 0.00% | 49% |
| Integra LifeSciences Holdings Corporation (IART) | 841 | -0.13% | 43% |
| Assertio Holdings, Inc. (ASRT) | 833 | -0.02% | 46% |
| Masimo Corporation (MASI) | 833 | -0.02% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.